Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
---|---|---|---|---|---|---|---|
1. | Nitrogen loss from Titan | VI Shematovich RE Johnson M Michael JG Luhmann |
2003 | ||||
2. | Ejection of nitrogen from Titan's atmosphere by magnetospheric ions and pick-up ions | M Michael RE Johnson F Leblanc M Liu JG Luhmann VI Shematovich |
2005 | ||||
3. | Energy deposition of pickup ions and heating of Titan's atmosphere | M Michael RE Johnson |
2005 | ||||
4. | A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer | S. J. Dawson M. Michael J. Biagi K. F. Foo M. Jefford S. Y. Ngan T. Leong A. Hui A. D. Milner R. J. S. Thomas J. R. Zalcberg |
2007 | ||||
5. | Cassini Ion and Neutral Mass Spectrometer data in Titan's upper atmosphere and exosphere: Observation of a suprathermal corona | V. De la Haye J. H. Waite R. E. Johnson R. V. Yelle T. E. Cravens J. G. Luhmann W. T. Kasprzak D. A. Gell B. Magee F. Leblanc M. Michael S. Jurac I. P. Robertson |
2007 | ||||
6. | Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally eadvanced pancreatic cancer | D. Goldstein G. Van Hazel E. Walpole C. Underhill D. Kotasek M. Michael J. Shapiro T. Davies W. Reece J. Harvey N. Spry |
2007 | ||||
7. | A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer | O. A. Khan M. Ranson M. Michael I. Olver N. C. Levitt P. Mortimer A. J. Watson G. P. Margison R. Midgley M. R. Middleton |
2008 | ||||
8. | Dust charging and electrical conductivity in the day and nighttime atmosphere of Mars | M. Michael S. N. Tripathi S. K. Mishra |
2008 | ||||
9. | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial | Robert Pirker Jose R. Pereira Aleksandra Szczesna Joachim von Pawel Maciej Krzakowski Rodryg Ramlau Ihor Vynnychenko Keunchil Park Chih-Teng Yu Valentyn Ganul Jae-Kyung Roh Emilio Bajetta Kenneth O'Byrne Filippo de Marinis Wilfried Eberhardt Thomas Goddemeier Michael Emig Ulrich Gatzemeier N. Thatcher J. P. Armand P. Camus N. Victor M. Emig M. Mueser K. Pilz T. Goddemeier I. Montaner Martin Lachs Loan Hoang-Sayag A. Alvarez F. Coppola G. Recondo E. Richardet F. Kirsten C. Karapetis P. Parente M. Michael S. White A. Boyce C. Lewis M. Slancar N. Pavlakis E. Abdi C. Underhill K. Pittman O. Burghuber R. Pirker R. Ruckser E. Ulsperger R. Kolb Y. Humblet J-L. Canon F. Bustin C. Barrios C. Gorini C. Moreira Ferreira J. Pereira N. Ivanova A. Tomova V. Tzekova P. Chilingirov M. Racheva M. Gill F. Javier Orlandi J. Reyes P. Salman M. Tomiskova J. Roubec M. Pesek J. Musil P. Zatloukal G. Robinet A. Riviere D. Moro-Sibilot F. Barlesi C. Chouaid J-M. Tourani H. Lena L. Thiberville E. Quoix R. Schott E. Lemarie G. Schlimok R. Loddenkemper W. Eberhardt H. Wilke U. Martens C. Waller J. von Pawel F. Griesinger U. Gatzemeier W. Schuette C. Eschbach H. Bischoff A. Chemaissani J. Wolf J. Fischer S. Bohnet H. Klein C. Kortsik C. Peschel T. H. Ittel W. Fett D. Chua P. Magyar G. Ostoros A. Somfay I. Vinkler Z. Papai B. Szima Z. Mark S. Tehenes K. O'Byrne A. Brandes A. Martoni G. Marini F. Artioli E. Bajetta S. Siena F. de Marinis A. Santoro S. Barni G. Berchem O. Arrieta J. Figueroa L. Martinez E. Llerena J. A. Burgers G. Giaccone F. M. N. H. Schramel S. H. Goey J. A. Stigt G. Jagiello A. Jagiello-Gruszfeld A. Szczesna R. Ramlau M. Krzakowski J. Tomeczko E. Teixeira B. Parente G. Kononova M. Biakhov V. Borisov V. Gorbunova A. Konev L. Manzuk Y. Lukyanov G. Manikhas S. Orlov D-S. Heo S-W. Kim K. Park J-K. Roh J-H. Choi R. Soo J. Mazal P. Kasan P. Berzinec M. Prochazka A. Carrato R. Bastus Pivlots P. Lianes J. Villar L. Paz-Ares M. Cobo J. M. Trigo A. Gurpide Ayarra M. Constenla A. Paredes Lario M. Lopez Brea A. Insa G. Lopez Vivanco O. Brodin G. Wagenius A. Ochsenbein D. Rauch A. Knuth G-C. Chang R. P. Perng C-H. Yang C-T. Yu A. Demirkazik F. Demirelli M. Nicolson S. Falk A. Price C. Mulatero S. M. Lee M. O'Brien J. Gardiner V. Laurence D. Ferry V. Paramonov I. Bondarenko M. Pylypenko V. Ganul P. Oliynichenko S. Simonov Y. Shparyk V. Bashtan I. Vynnychenko I. Galaychuk Y. Hotko |
2009 | ||||
10. | Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer | W. Chua D. Goldstein C. K. Lee H. Dhillon M. Michael P. Mitchell S. J. Clarke B. Iacopetta |
2009 | ||||
11. | Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study | E. Van Cutsem F. Rivera S. Berry A. Kretzschmar M. Michael M. DiBartolomeo M. -A. Mazier J. -L. Canon V. Georgoulias M. Peeters J. Bridgewater D. Cunningham |
2009 | ||||
12. | BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA | M. Michael I. Bruns E. Boelke F. Zohren A. Czibere N. N. Safaian F. Ncumann R. Haas G. Kobbe R. Fenk |
2010 | ||||
13. | Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer | N. M. Corcoran C. M. Hovens M. Michael M. A. Rosenthal A. J. Costello |
2010 | ||||
14. | Plant breeding and climate changes | S. Ceccarelli S. Grando M. Maatougui M. Michael M. Slash R. Haghparast M. Rahmanian A. Taheri A. Al-Yassin A. Benbelkacem M. Labdi H. Mimoun M. Nachit |
2010 | ||||
15. | FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy | F. L. Day E. Link S. Ngan T. Leong K. Moodie C. Lynch M. Michael E. de Winton A. Hogg R. J. Hicks A. Heriot |
2011 | ||||
16. | Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome | J. M. C. Yeung V. Kalff R. J. Hicks E. Drummond E. Link Y. Taouk M. Michael S. Ngan A. C. Lynch A. G. Heriot |
2011 | ||||
17. | ACTING PSYCHIATRY | C. Hickie M. Michael |
2014 | ||||
18. | Additive glycaemic control of the combination of a single dose of empagliflozin with injectable antidiabetes drugs in ZDF rats | E. K. Naderali L. Thomas R. Grempler M. Michael E. Mayoux A. Tahbaz |
2014 | ||||
19. | A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01 | S. Ngan M. Bressel B. McClure S. Chander J. McKendrick M. Steel J. Mackay P. Cooray M. Kumar A. Strickland A. Heriot T. Leong M. Michael |
2014 | ||||
20. | Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT) | G. Kong M. Thompson M. Collins A. Herschtal M. S. Hofman V. Johnston P. Eu M. Michael Rodney J. Hicks |
2014 | ||||
21. | AUDIT OF UPPER GI UNIT REFERRALS TO THE FAMILIAL CANCER CENTRE | T. Schenberg M. Michael |
2014 | ||||
22. | CREATIVE PRACTITIONERS | S. Kumar C. Hickie L. McLean M. Michael A. Pal N. Phillips |
2014 | ||||
23. | Disruption of cortical tension patterning drives the outgrowth of oncogenic cells | S. Wu G. A. Gomez M. Michael S. Verma H. Cox J. G. Lefevre R. G. Parton N. A. Hamilton A. S. Yap |
2014 | ||||
24. | Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer | M. Michael S. Chander J. McKendrick J. R. MacKay M. Steel R. Hicks A. Heriot T. Leong P. Cooray M. Jefford J. Zalcberg M. Bressel B. McClure S. Y. Ngan |
2014 | ||||
25. | Practicing Excellence in Transfusion: The Results of a Performance Improvement Project to Reduce Red Blood Cell Utilization at Virginia Commonwealth University, Richmond, Virginia | M. Michael B. Dahman S. Roseff M. Ailes N. Benoit |
2014 | ||||
26. | Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma | E. Kastritis F. Zagouri A. Symeonidis M. Roussou A. Sioni A. Pouli S. Delimpasi E. Katodritou E. Michalis M. Michael E. Hatzimichael A. Vassou P. Repousis A. Christophoridou Z. Kartasis E. Stefanoudaki C. Megalakaki S. Giannouli M-C Kyrtsonis K. Konstantopoulos M. Spyroupoulou-Vlachou E. Terpos M. A. Dimopoulos |
2014 | ||||
27. | Prison health as public health in Afghanistan? A policy analysis of the on-going reform process | M. Michael | 2014 | ||||
28. | Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents | M. A. Dimopoulos S. Delimpasi E. Katodritou A. Vassou M. C. Kyrtsonis P. Repousis Z. Kartasis A. Parcharidou M. Michael E. Michalis D. Gika A. Symeonidis A. Pouli K. Konstantopoulos E. Terpos E. Kastritis |
2014 | ||||
29. | Single dose of empagliflozin in combination with other oral antidiabetes drugs further improves glucose tolerance in ZDF rats | A. Tahbaz G. Luippold L. Thomas M. Michael E. Mayoux E. K. Naderali |
2014 | ||||
30. | SOCIAL CONSTRAINT AMONGST PEOPLE WITH ADVANCED CANCER: A CORRELATE WITH STIGMATISATION AND ANXIETY | Nicole Hennessy Anderson P. Schofield S. Aranda S. Chambers M. Krishnasamy D. Ball M. Michael P. Kenny R. Lipson-Smith I. Stubbins A. Ugalde |
2014 | ||||
31. | The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice | E. Mayoux T. Klein R. Grempler M. Michael A. Tahbaz E. K. Naderali |
2014 | ||||
32. | The novel SGLT-2 inhibitor, empagliflozin, prevents pioglitazone-induced weight gain and further improves glycaemic control in dietary-induced obese rats | E. K. Naderali R. Grempler L. Thomas A. Sauer M. Michael P. Eickelmann T. Klein E. Mayoux A. Tahbaz |
2014 | ||||
33. | The Safety and Tolerability of Veliparib (V) plus Capecitabine (C) and Radiation (RT) in Subjects with Locally Advanced Rectal Cancer (LARC): Results of a Phase 1b Study | B. Czito M. Mulcahy W. Schelman H. Vaghefi J. Gayle A. Deluca H. Xiong W. Munasinghe D. Matthew K. Holen M. Michael |
2014 | ||||
34. | Validation of radio-frequency dielectric heating system for destruction of Cronobacter sakazakii and Salmonella species in nonfat dry milk | M. Michael R. K. Phebus H. Thippareddi J. Subbiah S. L. Birla K. A. Schmidt |
2014 | ||||
35. | Safety and Tolerability of Veliparib Combined With Capecitabine Plus Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Final Results of a Phase 1b Study | B. Czito M. Mulcahy D. Deming H. Vaghefi G. Jameson A. DeLuca H. Xiong W. Munasinghe M. Dudley P. Komarnitsky K. Holen M. Michael |
2015 | ||||
36. | The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care | T. Price N. Pavlakis C. Karapetis M. Michael N. Singhal D. Goldstein G. Van Hazel J. Zalcberg R. Hicks S. Yeend Y. J. Chua |
2015 | ||||
37. | A 12-week regimen with interdigitating FOLFOX/bevacizumab and pelvic chemoradiation for synchronous primary and metastatic rectal cancer. The CHROME B trial | S. Ngan M. Bressel J. Chu J. McKendrick S. Chander P. Cooray M. Jefford R. Wong M. Steel T. Leong A. Heriot M. Michael |
2016 | ||||
38. | A photochemicalmodel of the dust-loaded ionosphere of Mars | S. Cardnell O. Witasse G. J. Molina-Cuberos M. Michael S. N. Tripathi G. Deprez F. Montmessin K. O'Brien |
2016 | ||||
39. | Favourable responses in Patients with Bulky Neuroendocrine Tumours (NET) A Personalised Approach Using 90Y-DOTA-Octreotate Sequenced with 177Lu-DOTA-Octreotate Induction Peptide Receptor Chemoradionuclide Therapy (PRCRT) | G. Kong J. Callahan M. Hofman D. Pattison T. Akhurst M. Michael P. Eu R. Hicks |
2016 | ||||
40. | Genomic Variants in the SLCO1B3 Gene May Serve as Pharmacogenomic Biomarkers upon Cancer Drug Administration | A. Stratopoulos M. Michael C. -V. Zafeiri E. Daki T. Katsila G. P. Patrinos |
2016 | ||||
41. | HIGH EFFICACY FROM A PERSONALISED APPROACH USING Y-90-DOTA-OCTREOTATE SEQUENCED WITH (LU)-L-177-DOTA-OCTREOTATE INDUCTION PEPTIDE RECEPTOR CHEMORADIONUCLIDE THERAPY (PRCRT) FOR BULKY NEUROENDOCRINE TUMOURS | G. Kong J. Callahan M. Hofman D. Pattison T. Akhurst M. Michael P. Eu R. Hicks |
2016 | ||||
42. | Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection | S. Pol A. Aghemo L. Lin R. Hyland C. Yun J. Spellman M. Natha D. Brainard J. McHutchison M. Bourliere M. Peck-Radosavljevic M. Michael M. Colombo |
2016 | ||||
43. | PRELIMINARY RESULTS OF (68)GA EXENDIN-4 PET/CT IMAGING OF NEUROENDOCRINE TUMOURS (NETS) | D. Pattison G. Kong B. Messazos P. Hamblin S. Fourlanos M. Lee M. Michael E. Hong P. Eu R. Hicks |
2016 | ||||
44. | THE ENDOTHELIAL PHD2/HIF-2 AXIS REGULATES PULMONARY ARTERY PRESSURE IN MICE | P. P. Kapitsinou G. Rajendran L. Astleford M. P. Schonfeld M. Michael S. Shay J. L. French J. West V. H. Haase T. Fields |
2016 | ||||
45. | UNIVERSITY OF SOUTH FLORIDA, TAMPA FAMILY HEALTH CENTER, AND SENIOR CONNECTION PARTNERSHIP | R. DAoust K. Hyer L. Guerra A. Badana F. Syed C. McHenry M. Michael C. Wilson |
2016 | ||||
46. | Application of Curriculum Mapping Concepts to Integrate Multidisciplinary Competencies in the Care of Older Adults in Graduate Nurse Practitioner Curricula | C. Burkey-Wilson M. Michael |
2017 | ||||
47. | A REVISED STAGING SYSTEM FOR WALDENSTROM'S MACROGLOBULINEMIA | E. Kastritis M. Gavriatopoulou M. C. Kyrtsonis E. Hatjiharissi E. Katodritou P. Repousis A. Symeonidis M. Michael A. Pouli N. Giannakoulas D. Christoulas A. Megalakaki P. Tsirigotis S. Giannouli P. Panagiotidis E. Vervessou E. Spanoudakis E. Terpos M. A. Dimopoulos |
2017 | ||||
48. | FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases | Bird, T Michael, M Bressel, M Chu, J Chander, S Cooray, P McKendrick, J Jefford, M Heriot, A Steel, M Leong, T Ngan, S |
2017 | ||||
49. | Midpole Ureterocalycostomy for Renal Transplant Salvage: A Pediatric Case Report. | Imani, PD White, JT Michael, M Puttmann, KT O'Mahony, CA Koh, CJ |
2018 | ||||
50. | Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis. | Kong, JC Guerra, GR Warrier, SK Lynch, AC Michael, M Ngan, SY Phillips, W Ramsay, G Heriot, AG |
2018 | ||||
51. | [Systematic analysis of airway registries in emergency medicine]. | Girrbach, FF Hilbig, F Michael, M Bernhard, M |
2018 | ||||
52. | [36-years-old male following motorcycle accident with high velocity trauma : Preparation for the medical specialist examination: part 34]. | Michael, M Picker, O Bernhard, M |
2019 | ||||
53. | [Resuscitation room management for trauma patients]. | Thelen, S Michael, M Ashmawy, H Knoefel, WT Picker, O Windolf, J Bernhard, M |
2019 | ||||
54. | Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. | Narasimhan, V Tan, S Kong, J Pham, T Michael, M Ramsay, R Warrier, S Heriot, A |
2020 | ||||
55. | An Experimental Study on the Rheological Behavior of Carbon Black-Boron Nitride Hybrid Nanofluids and Development of a New Correlation. | Michael, M Zagabathuni, A Kumar Pabi, S Ghosh, S |
2021 | ||||
56. | Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study. | Behrenbruch, C Prabhakaran, S Udayasiri D, D Michael, M Hollande, F Hayes, I Heriot, AG Knowles, B Thomson, BN |
2021 | ||||
57. | Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. | Wilson, K Flood, M Narasimhan, V Pham, T Warrier, S Ramsay, R Michael, M Heriot, A |
2021 | ||||
58. | Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters. | Sundararajan, SH Ramos, AD Kishore, V Michael, M Doustaly, R DeRusso, F Patsalides, A |
2021 | ||||
59. | Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review. | Wilson, KC Flood, MP Oh, D Calvin, N Michael, M Ramsay, RG Heriot, AG |
2021 | ||||
60. | Impact of gas micro-nano-bubbles on the efficacy of commonly used antimicrobials in the food industry. | Singh, A Sekhon, AS Unger, P Babb, M Yang, Y Michael, M |
2021 | ||||
61. | [Nontraumatic resuscitation room management of critically ill patients]. | Michael, M Kumle, B Pin, M Kümpers, P Gröning, I Bernhard, M |
2021 | ||||
62. | [Optimization of microbial diagnostics by introduction of a blood culture standard operating procedure in the emergency department]. | Orth, HM Al Agha, S Kempe, M Mackenzie, C Michael, M Bernhard, M Jensen, B-O |
2021 | ||||
63. | TEMPORARY REMOVAL: OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. | Alexander, M Harris, SJ Underhill, C Torres, J Sharma, S Lee, N Wong, H Eek, R Michael, M Tie, J Rogers, J Heriot, A Ball, D MacManus, M Wolfe, R Solomon, B Burbury, K |
2022 | ||||
64. | TEMPORARY REMOVAL: PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. | Alexander, M Harris, SJ Underhill, C Torres, J Sharma, S Lee, N Wong, H Eek, R Michael, M Tie, J Rogers, J Heriot, A Ball, D MacManus, M Wolfe, R Solomon, B Burbury, K |
2022 | Count | 0 | 17 | 48 | 0 |
Title | Authors | Year | Publication name | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | รวม |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases. | Bird, T Michael, M Bressel, M Chu, J Chander, S Cooray, P McKendrick, J Jefford, M Heriot, A Steel, M Leong, T Ngan, S |
2017 |
Acta oncologica (Stockholm, Sweden) (), pp. 1-7 |
|
2. | [Systematic analysis of airway registries in emergency medicine]. | Girrbach, FF Hilbig, F Michael, M Bernhard, M |
2018 |
Der Anaesthesist 9 (67), pp. 664-673 |
|
3. | Midpole Ureterocalycostomy for Renal Transplant Salvage: A Pediatric Case Report. | Imani, PD White, JT Michael, M Puttmann, KT O'Mahony, CA Koh, CJ |
2018 |
Transplantation proceedings 3 (50), pp. 887-890 |
|
4. | Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis. | Kong, JC Guerra, GR Warrier, SK Lynch, AC Michael, M Ngan, SY Phillips, W Ramsay, G Heriot, AG |
2018 |
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 7 (20), pp. 574-585 |
|
5. | [36-years-old male following motorcycle accident with high velocity trauma : Preparation for the medical specialist examination: part 34]. | Michael, M Picker, O Bernhard, M |
2019 |
Der Anaesthesist 0 (68), pp. 239-242 |
|
6. | [Resuscitation room management for trauma patients]. | Thelen, S Michael, M Ashmawy, H Knoefel, WT Picker, O Windolf, J Bernhard, M |
2019 |
Der Anaesthesist 1 (68), pp. 49-66 |
|
7. | Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. | Narasimhan, V Tan, S Kong, J Pham, T Michael, M Ramsay, R Warrier, S Heriot, A |
2020 |
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 11 (22), pp. 1482-1495 |
|
8. | [Nontraumatic resuscitation room management of critically ill patients]. | Michael, M Kumle, B Pin, M Kümpers, P Gröning, I Bernhard, M |
2021 |
Medizinische Klinik, Intensivmedizin und Notfallmedizin 5 (116), pp. 405-414 |
|
9. | Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review. | Wilson, K Flood, M Narasimhan, V Pham, T Warrier, S Ramsay, R Michael, M Heriot, A |
2021 |
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 8 (47), pp. 1862-1874 |
|
10. | Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review. | Wilson, KC Flood, MP Oh, D Calvin, N Michael, M Ramsay, RG Heriot, AG |
2021 |
Annals of surgical oncology 12 (28), pp. 7463-7473 |
|
11. | Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters. | Sundararajan, SH Ramos, AD Kishore, V Michael, M Doustaly, R DeRusso, F Patsalides, A |
2021 |
AJNR. American journal of neuroradiology 2 (42), pp. 288-296 |
|
12. | An Experimental Study on the Rheological Behavior of Carbon Black-Boron Nitride Hybrid Nanofluids and Development of a New Correlation. | Michael, M Zagabathuni, A Kumar Pabi, S Ghosh, S |
2021 |
Journal of nanoscience and nanotechnology 6 (21), pp. 3283-3290 |
|
13. | [Optimization of microbial diagnostics by introduction of a blood culture standard operating procedure in the emergency department]. | Orth, HM Al Agha, S Kempe, M Mackenzie, C Michael, M Bernhard, M Jensen, B-O |
2021 |
Medizinische Klinik, Intensivmedizin und Notfallmedizin 8 (116), pp. 687-693 |
|
14. | Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study. | Behrenbruch, C Prabhakaran, S Udayasiri D, D Michael, M Hollande, F Hayes, I Heriot, AG Knowles, B Thomson, BN |
2021 |
Journal of surgical oncology 5 (123), pp. 1263-1273 |
|
15. | Impact of gas micro-nano-bubbles on the efficacy of commonly used antimicrobials in the food industry. | Singh, A Sekhon, AS Unger, P Babb, M Yang, Y Michael, M |
2021 |
Journal of applied microbiology 4 (130), pp. 1092-1105 |
|
16. | TEMPORARY REMOVAL: OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial. | Alexander, M Harris, SJ Underhill, C Torres, J Sharma, S Lee, N Wong, H Eek, R Michael, M Tie, J Rogers, J Heriot, A Ball, D MacManus, M Wolfe, R Solomon, B Burbury, K |
2022 |
Thrombosis research (213), pp. S9 |
|
17. | TEMPORARY REMOVAL: PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score. | Alexander, M Harris, SJ Underhill, C Torres, J Sharma, S Lee, N Wong, H Eek, R Michael, M Tie, J Rogers, J Heriot, A Ball, D MacManus, M Wolfe, R Solomon, B Burbury, K |
2022 |
Thrombosis research (213), pp. S31-S32 |
Title | Authors | Year | Journal title | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | รวม | ||||||
1. | Nitrogen loss from Titan | VI Shematovich RE Johnson M Michael JG Luhmann |
2003 |
JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS E8 (108.0), pp. |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
2. | Ejection of nitrogen from Titan's atmosphere by magnetospheric ions and pick-up ions | M Michael RE Johnson F Leblanc M Liu JG Luhmann VI Shematovich |
2005 |
ICARUS 1.0 (175.0), pp. 263.0-267.0 |
44 | 0 | 0 | 0 | 0 | 0 | 44 | |
3. | Energy deposition of pickup ions and heating of Titan's atmosphere | M Michael RE Johnson |
2005 |
PLANETARY AND SPACE SCIENCE 14-15 (53.0), pp. 1510.0-1514.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
4. | A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer | S. J. Dawson M. Michael J. Biagi K. F. Foo M. Jefford S. Y. Ngan T. Leong A. Hui A. D. Milner R. J. S. Thomas J. R. Zalcberg |
2007 |
INVESTIGATIONAL NEW DRUGS 2.0 (25.0), pp. 123.0-129.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
5. | Cassini Ion and Neutral Mass Spectrometer data in Titan's upper atmosphere and exosphere: Observation of a suprathermal corona | V. De la Haye J. H. Waite R. E. Johnson R. V. Yelle T. E. Cravens J. G. Luhmann W. T. Kasprzak D. A. Gell B. Magee F. Leblanc M. Michael S. Jurac I. P. Robertson |
2007 |
JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS A7 (112.0), pp. |
63 | 0 | 0 | 0 | 0 | 0 | 63 | |
6. | Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally eadvanced pancreatic cancer | D. Goldstein G. Van Hazel E. Walpole C. Underhill D. Kotasek M. Michael J. Shapiro T. Davies W. Reece J. Harvey N. Spry |
2007 |
BRITISH JOURNAL OF CANCER 4.0 (97.0), pp. 464.0-471.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
7. | A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer | O. A. Khan M. Ranson M. Michael I. Olver N. C. Levitt P. Mortimer A. J. Watson G. P. Margison R. Midgley M. R. Middleton |
2008 |
BRITISH JOURNAL OF CANCER 10.0 (98.0), pp. 1614.0-1618.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
8. | Dust charging and electrical conductivity in the day and nighttime atmosphere of Mars | M. Michael S. N. Tripathi S. K. Mishra |
2008 |
JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS E7 (113.0), pp. |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
9. | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial | Robert Pirker Jose R. Pereira Aleksandra Szczesna Joachim von Pawel Maciej Krzakowski Rodryg Ramlau Ihor Vynnychenko Keunchil Park Chih-Teng Yu Valentyn Ganul Jae-Kyung Roh Emilio Bajetta Kenneth O'Byrne Filippo de Marinis Wilfried Eberhardt Thomas Goddemeier Michael Emig Ulrich Gatzemeier N. Thatcher J. P. Armand P. Camus N. Victor M. Emig M. Mueser K. Pilz T. Goddemeier I. Montaner Martin Lachs Loan Hoang-Sayag A. Alvarez F. Coppola G. Recondo E. Richardet F. Kirsten C. Karapetis P. Parente M. Michael S. White A. Boyce C. Lewis M. Slancar N. Pavlakis E. Abdi C. Underhill K. Pittman O. Burghuber R. Pirker R. Ruckser E. Ulsperger R. Kolb Y. Humblet J-L. Canon F. Bustin C. Barrios C. Gorini C. Moreira Ferreira J. Pereira N. Ivanova A. Tomova V. Tzekova P. Chilingirov M. Racheva M. Gill F. Javier Orlandi J. Reyes P. Salman M. Tomiskova J. Roubec M. Pesek J. Musil P. Zatloukal G. Robinet A. Riviere D. Moro-Sibilot F. Barlesi C. Chouaid J-M. Tourani H. Lena L. Thiberville E. Quoix R. Schott E. Lemarie G. Schlimok R. Loddenkemper W. Eberhardt H. Wilke U. Martens C. Waller J. von Pawel F. Griesinger U. Gatzemeier W. Schuette C. Eschbach H. Bischoff A. Chemaissani J. Wolf J. Fischer S. Bohnet H. Klein C. Kortsik C. Peschel T. H. Ittel W. Fett D. Chua P. Magyar G. Ostoros A. Somfay I. Vinkler Z. Papai B. Szima Z. Mark S. Tehenes K. O'Byrne A. Brandes A. Martoni G. Marini F. Artioli E. Bajetta S. Siena F. de Marinis A. Santoro S. Barni G. Berchem O. Arrieta J. Figueroa L. Martinez E. Llerena J. A. Burgers G. Giaccone F. M. N. H. Schramel S. H. Goey J. A. Stigt G. Jagiello A. Jagiello-Gruszfeld A. Szczesna R. Ramlau M. Krzakowski J. Tomeczko E. Teixeira B. Parente G. Kononova M. Biakhov V. Borisov V. Gorbunova A. Konev L. Manzuk Y. Lukyanov G. Manikhas S. Orlov D-S. Heo S-W. Kim K. Park J-K. Roh J-H. Choi R. Soo J. Mazal P. Kasan P. Berzinec M. Prochazka A. Carrato R. Bastus Pivlots P. Lianes J. Villar L. Paz-Ares M. Cobo J. M. Trigo A. Gurpide Ayarra M. Constenla A. Paredes Lario M. Lopez Brea A. Insa G. Lopez Vivanco O. Brodin G. Wagenius A. Ochsenbein D. Rauch A. Knuth G-C. Chang R. P. Perng C-H. Yang C-T. Yu A. Demirkazik F. Demirelli M. Nicolson S. Falk A. Price C. Mulatero S. M. Lee M. O'Brien J. Gardiner V. Laurence D. Ferry V. Paramonov I. Bondarenko M. Pylypenko V. Ganul P. Oliynichenko S. Simonov Y. Shparyk V. Bashtan I. Vynnychenko I. Galaychuk Y. Hotko |
2009 |
LANCET 9674.0 (373.0), pp. 1525.0-1531.0 |
801 | 0 | 0 | 0 | 0 | 0 | 801 | |
10. | Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer | W. Chua D. Goldstein C. K. Lee H. Dhillon M. Michael P. Mitchell S. J. Clarke B. Iacopetta |
2009 |
BRITISH JOURNAL OF CANCER 6.0 (101.0), pp. 998.0-1004.0 |
50 | 0 | 0 | 0 | 0 | 0 | 50 | |
11. | Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study | E. Van Cutsem F. Rivera S. Berry A. Kretzschmar M. Michael M. DiBartolomeo M. -A. Mazier J. -L. Canon V. Georgoulias M. Peeters J. Bridgewater D. Cunningham |
2009 |
ANNALS OF ONCOLOGY 11.0 (20.0), pp. 1842.0-1847.0 |
297 | 0 | 0 | 0 | 0 | 0 | 297 | |
12. | BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA | M. Michael I. Bruns E. Boelke F. Zohren A. Czibere N. N. Safaian F. Ncumann R. Haas G. Kobbe R. Fenk |
2010 |
EUROPEAN JOURNAL OF MEDICAL RESEARCH 1.0 (15.0), pp. 13.0-19.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
13. | BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA | M. Michael I. Bruns E. Boelke F. Zohren A. Czibere N. N. Safaian F. Ncumann R. Haas G. Kobbe R. Fenk |
2010 |
EUROPEAN JOURNAL OF MEDICAL RESEARCH 1.0 (15.0), pp. 13.0-19.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
14. | Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer | N. M. Corcoran C. M. Hovens M. Michael M. A. Rosenthal A. J. Costello |
2010 |
BRITISH JOURNAL OF CANCER 4.0 (103.0), pp. 462.0-468.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
15. | Plant breeding and climate changes | S. Ceccarelli S. Grando M. Maatougui M. Michael M. Slash R. Haghparast M. Rahmanian A. Taheri A. Al-Yassin A. Benbelkacem M. Labdi H. Mimoun M. Nachit |
2010 |
JOURNAL OF AGRICULTURAL SCIENCE (148.0), pp. 627.0-637.0 |
55 | 0 | 0 | 0 | 0 | 0 | 55 | |
16. | FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy | F. L. Day E. Link S. Ngan T. Leong K. Moodie C. Lynch M. Michael E. de Winton A. Hogg R. J. Hicks A. Heriot |
2011 |
BRITISH JOURNAL OF CANCER 4.0 (105.0), pp. 498.0-504.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
17. | FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy | F. L. Day E. Link S. Ngan T. Leong K. Moodie C. Lynch M. Michael E. de Winton A. Hogg R. J. Hicks A. Heriot |
2011 |
BRITISH JOURNAL OF CANCER 4.0 (105.0), pp. 498.0-504.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
18. | Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome | J. M. C. Yeung V. Kalff R. J. Hicks E. Drummond E. Link Y. Taouk M. Michael S. Ngan A. C. Lynch A. G. Heriot |
2011 |
DISEASES OF THE COLON & RECTUM 5.0 (54.0), pp. 518.0-525.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
19. | ACTING PSYCHIATRY | C. Hickie M. Michael |
2014 |
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (48.0), pp. 69.0-70.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
20. | Additive glycaemic control of the combination of a single dose of empagliflozin with injectable antidiabetes drugs in ZDF rats | E. K. Naderali L. Thomas R. Grempler M. Michael E. Mayoux A. Tahbaz |
2014 |
DIABETIC MEDICINE (31.0), pp. 65.0-66.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
21. | A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01 | S. Ngan M. Bressel B. McClure S. Chander J. McKendrick M. Steel J. Mackay P. Cooray M. Kumar A. Strickland A. Heriot T. Leong M. Michael |
2014 |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (90.0), pp. S21-S22 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
22. | Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT) | G. Kong M. Thompson M. Collins A. Herschtal M. S. Hofman V. Johnston P. Eu M. Michael Rodney J. Hicks |
2014 |
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 10.0 (41.0), pp. 1831.0-1844.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
23. | AUDIT OF UPPER GI UNIT REFERRALS TO THE FAMILIAL CANCER CENTRE | T. Schenberg M. Michael |
2014 |
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (10.0), pp. 65.0-66.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
24. | CREATIVE PRACTITIONERS | S. Kumar C. Hickie L. McLean M. Michael A. Pal N. Phillips |
2014 |
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (48.0), pp. 69.0-69.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
25. | Disruption of cortical tension patterning drives the outgrowth of oncogenic cells | S. Wu G. A. Gomez M. Michael S. Verma H. Cox J. G. Lefevre R. G. Parton N. A. Hamilton A. S. Yap |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S67-S67 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
26. | Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer | M. Michael S. Chander J. McKendrick J. R. MacKay M. Steel R. Hicks A. Heriot T. Leong P. Cooray M. Jefford J. Zalcberg M. Bressel B. McClure S. Y. Ngan |
2014 |
BRITISH JOURNAL OF CANCER 10.0 (111.0), pp. 1924.0-1931.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
27. | Practicing Excellence in Transfusion: The Results of a Performance Improvement Project to Reduce Red Blood Cell Utilization at Virginia Commonwealth University, Richmond, Virginia | M. Michael B. Dahman S. Roseff M. Ailes N. Benoit |
2014 |
TRANSFUSION 8.0 (54.0), pp. 11A-12A |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
28. | Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma | E. Kastritis F. Zagouri A. Symeonidis M. Roussou A. Sioni A. Pouli S. Delimpasi E. Katodritou E. Michalis M. Michael E. Hatzimichael A. Vassou P. Repousis A. Christophoridou Z. Kartasis E. Stefanoudaki C. Megalakaki S. Giannouli M-C Kyrtsonis K. Konstantopoulos M. Spyroupoulou-Vlachou E. Terpos M. A. Dimopoulos |
2014 |
LEUKEMIA 10.0 (28.0), pp. 2075.0-2079.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
29. | Prison health as public health in Afghanistan? A policy analysis of the on-going reform process | M. Michael | 2014 |
PUBLIC HEALTH 5.0 (128.0), pp. 478.0-481.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
30. | Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents | M. A. Dimopoulos S. Delimpasi E. Katodritou A. Vassou M. C. Kyrtsonis P. Repousis Z. Kartasis A. Parcharidou M. Michael E. Michalis D. Gika A. Symeonidis A. Pouli K. Konstantopoulos E. Terpos E. Kastritis |
2014 |
ANNALS OF ONCOLOGY 1.0 (25.0), pp. 195.0-200.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
31. | Single dose of empagliflozin in combination with other oral antidiabetes drugs further improves glucose tolerance in ZDF rats | A. Tahbaz G. Luippold L. Thomas M. Michael E. Mayoux E. K. Naderali |
2014 |
DIABETIC MEDICINE (31.0), pp. 65.0-65.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
32. | SOCIAL CONSTRAINT AMONGST PEOPLE WITH ADVANCED CANCER: A CORRELATE WITH STIGMATISATION AND ANXIETY | Nicole Hennessy Anderson P. Schofield S. Aranda S. Chambers M. Krishnasamy D. Ball M. Michael P. Kenny R. Lipson-Smith I. Stubbins A. Ugalde |
2014 |
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (10.0), pp. 128.0-128.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
33. | The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice | E. Mayoux T. Klein R. Grempler M. Michael A. Tahbaz E. K. Naderali |
2014 |
DIABETIC MEDICINE (31.0), pp. 66.0-66.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
34. | The novel SGLT-2 inhibitor, empagliflozin, prevents pioglitazone-induced weight gain and further improves glycaemic control in dietary-induced obese rats | E. K. Naderali R. Grempler L. Thomas A. Sauer M. Michael P. Eickelmann T. Klein E. Mayoux A. Tahbaz |
2014 |
DIABETIC MEDICINE (31.0), pp. 66.0-66.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
35. | The Safety and Tolerability of Veliparib (V) plus Capecitabine (C) and Radiation (RT) in Subjects with Locally Advanced Rectal Cancer (LARC): Results of a Phase 1b Study | B. Czito M. Mulcahy W. Schelman H. Vaghefi J. Gayle A. Deluca H. Xiong W. Munasinghe D. Matthew K. Holen M. Michael |
2014 |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (90.0), pp. S22-S22 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
36. | Validation of radio-frequency dielectric heating system for destruction of Cronobacter sakazakii and Salmonella species in nonfat dry milk | M. Michael R. K. Phebus H. Thippareddi J. Subbiah S. L. Birla K. A. Schmidt |
2014 |
JOURNAL OF DAIRY SCIENCE 12.0 (97.0), pp. 7316.0-7324.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
37. | Safety and Tolerability of Veliparib Combined With Capecitabine Plus Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Final Results of a Phase 1b Study | B. Czito M. Mulcahy D. Deming H. Vaghefi G. Jameson A. DeLuca H. Xiong W. Munasinghe M. Dudley P. Komarnitsky K. Holen M. Michael |
2015 |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 3.0 (93.0), pp. S206-S206 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
38. | The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care | T. Price N. Pavlakis C. Karapetis M. Michael N. Singhal D. Goldstein G. Van Hazel J. Zalcberg R. Hicks S. Yeend Y. J. Chua |
2015 |
NEUROENDOCRINOLOGY 1-2 (102.0), pp. 98.0-98.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
39. | A 12-week regimen with interdigitating FOLFOX/bevacizumab and pelvic chemoradiation for synchronous primary and metastatic rectal cancer. The CHROME B trial | S. Ngan M. Bressel J. Chu J. McKendrick S. Chander P. Cooray M. Jefford R. Wong M. Steel T. Leong A. Heriot M. Michael |
2016 |
ANNALS OF ONCOLOGY (27.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
40. | A photochemicalmodel of the dust-loaded ionosphere of Mars | S. Cardnell O. Witasse G. J. Molina-Cuberos M. Michael S. N. Tripathi G. Deprez F. Montmessin K. O'Brien |
2016 |
JOURNAL OF GEOPHYSICAL RESEARCH-PLANETS 11.0 (121.0), pp. 2335.0-2348.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
41. | Favourable responses in Patients with Bulky Neuroendocrine Tumours (NET) A Personalised Approach Using 90Y-DOTA-Octreotate Sequenced with 177Lu-DOTA-Octreotate Induction Peptide Receptor Chemoradionuclide Therapy (PRCRT) | G. Kong J. Callahan M. Hofman D. Pattison T. Akhurst M. Michael P. Eu R. Hicks |
2016 |
NEUROENDOCRINOLOGY (103.0), pp. 93.0-93.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
42. | Genomic Variants in the SLCO1B3 Gene May Serve as Pharmacogenomic Biomarkers upon Cancer Drug Administration | A. Stratopoulos M. Michael C. -V. Zafeiri E. Daki T. Katsila G. P. Patrinos |
2016 |
PUBLIC HEALTH GENOMICS (19.0), pp. 8.0-9.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
43. | HIGH EFFICACY FROM A PERSONALISED APPROACH USING Y-90-DOTA-OCTREOTATE SEQUENCED WITH (LU)-L-177-DOTA-OCTREOTATE INDUCTION PEPTIDE RECEPTOR CHEMORADIONUCLIDE THERAPY (PRCRT) FOR BULKY NEUROENDOCRINE TUMOURS | G. Kong J. Callahan M. Hofman D. Pattison T. Akhurst M. Michael P. Eu R. Hicks |
2016 |
INTERNAL MEDICINE JOURNAL (46.0), pp. 25.0-25.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
44. | Ledipasvir/Sofosbuvir (LDV/SOF) for 12 or 24 Weeks Is Safe and Effective in Kidney Transplant Recipients with Chronic Genotype 1 or 4 HCV Infection | S. Pol A. Aghemo L. Lin R. Hyland C. Yun J. Spellman M. Natha D. Brainard J. McHutchison M. Bourliere M. Peck-Radosavljevic M. Michael M. Colombo |
2016 |
AMERICAN JOURNAL OF TRANSPLANTATION (16.0), pp. 262.0-262.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
45. | PRELIMINARY RESULTS OF (68)GA EXENDIN-4 PET/CT IMAGING OF NEUROENDOCRINE TUMOURS (NETS) | D. Pattison G. Kong B. Messazos P. Hamblin S. Fourlanos M. Lee M. Michael E. Hong P. Eu R. Hicks |
2016 |
INTERNAL MEDICINE JOURNAL (46.0), pp. 23.0-23.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
46. | THE ENDOTHELIAL PHD2/HIF-2 AXIS REGULATES PULMONARY ARTERY PRESSURE IN MICE | P. P. Kapitsinou G. Rajendran L. Astleford M. P. Schonfeld M. Michael S. Shay J. L. French J. West V. H. Haase T. Fields |
2016 |
JOURNAL OF INVESTIGATIVE MEDICINE 4.0 (64.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
47. | UNIVERSITY OF SOUTH FLORIDA, TAMPA FAMILY HEALTH CENTER, AND SENIOR CONNECTION PARTNERSHIP | R. DAoust K. Hyer L. Guerra A. Badana F. Syed C. McHenry M. Michael C. Wilson |
2016 |
GERONTOLOGIST (56.0), pp. 449.0-449.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
48. | Application of Curriculum Mapping Concepts to Integrate Multidisciplinary Competencies in the Care of Older Adults in Graduate Nurse Practitioner Curricula | C. Burkey-Wilson M. Michael |
2017 |
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (65.0), pp. S56-S57 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
49. | A REVISED STAGING SYSTEM FOR WALDENSTROM'S MACROGLOBULINEMIA | E. Kastritis M. Gavriatopoulou M. C. Kyrtsonis E. Hatjiharissi E. Katodritou P. Repousis A. Symeonidis M. Michael A. Pouli N. Giannakoulas D. Christoulas A. Megalakaki P. Tsirigotis S. Giannouli P. Panagiotidis E. Vervessou E. Spanoudakis E. Terpos M. A. Dimopoulos |
2017 |
HAEMATOLOGICA (102.0), pp. 146.0-147.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
50. | FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases | T. Bird M. Michael M. Bressel J. Chu S. Chander P. Cooray J. McKendrick M. Jefford A. Heriot M. Steel T. Leong S. Ngan |
2017 |
ACTA ONCOLOGICA 5.0 (56.0), pp. 646.0-652.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 |
Title | Authors | Year | Journal title |
---|
ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
---|